Johnson & Johnson (JNJ) Recalling 2 Hip Replacement Systems

August 27, 2010, 3:21 PM

Johnson & Johnson (NYSE: JNJ) has announced a voluntary recall of two hip-replacement systems due to a higher rate of revision surgeries required by patients. The most recent recall comes only two days after getting a warning from the FDA that it is illegally marketing two other products.

DePuy Orthopaedics Inc., Johnson & Johnsons Orthopaedics unit, announced on Thursday it is recalling two hip replacement products because most recent data shows that within 5 years, every 1 in 8 patients need a second hip replacement procedure.

The recalled hip replacement systems are the ASR XL Acetabular System, which is the cup portion of the hip joint, was launched in 2004 and is available world wide. The other is the ASR Hip Resurfacing System, a partial hip replacement that involves the placing of a metal cap on the ball of the hip bone, was launched in 2003 and available for sale outside the U.S. only.

The company is requesting patients with an ASR device visit their surgeons for a check up of device performance and suggests yearly monitoring to recheck it. Johnson & Johnson said  it intends to cover costs of monitoring and treatment for services, including revision surgeries.

Johnson & Johnson shares closed at $57.60, up 34 cents.

Related Articles

• Johnson & Johnson (JNJ) to Begin Shipping Out Tylenol Cold & Flu Caplets Since Recall
• Johnson & Johnson (JNJ) Ordered to Pay $52 Million for Drug Pricing Problems
• Johnson & Johnson (JNJ) Reviews Possible Contamination At Crucell facility in South Korea

Tags: Johnson & Johnson, NYSE, Recall